Government-Owned Inventions; Availability for Licensing, 41972-41973 [2017-18670]
Download as PDF
41972
Federal Register / Vol. 82, No. 170 / Tuesday, September 5, 2017 / Notices
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: NCI Cancer
Genetics Services Directory Web-Based
Application and Update Mailer, 0925–
professionals who provide services
related to cancer genetics. The
information collected on the application
form includes name, professional
qualifications, practice locations, and
the area of specialization. The
information is updated annually using a
Web-based update mailer that mirrors
the application form.
The NCI Cancer Genetics Services
Directory is a unique resource for cancer
patients and their families who are
looking for information about their
family risk of cancer and genetic
counseling. Collecting applicant
information and verifying it annually by
using the NCI Cancer Genetics Services
Directory Web-based Application Form
and Update Mailer is important for
providing this information to the public
and for keeping it current.
OMB approval is requested for 3 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 180.
0639, Extension, National Cancer
Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: The Office of
Communications and Public Liaison has
created the NCI Cancer Genetics
Services Directory on NCI’s Web site
Cancer.gov. This directory is a
searchable collection of information
about professionals who provide
services related to cancer genetics.
These services include cancer risk
assessment, genetic counseling, and
genetic susceptibility testing. The
professionals have applied to be in the
directory using an online application
form and have met basic criteria
outlined on the form.
There are currently 552 genetics
professionals listed in the directory.
Approximately 30–60 new professionals
are added to the directory each year.
The applicants are nurses, physicians,
genetic counselors, and other
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden
per response
(in hours)
Total annual
burden Hours
Form name
Type of respondent
Web-based Application Form ............
Web-based Update Mailer ................
Genetics Professional ......................
Genetics Professional ......................
60
600
1
1
30/60
15/60
30
150
Totals ..........................................
..........................................................
660
660
........................
180
Dated: August 21, 2017.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2017–18667 Filed 9–1–17; 8:45 am]
Room 4A29, MSC2479, Bethesda, MD
20892–2479; telephone: 301–402–5579.
A signed Confidential Disclosure
Agreement may be required to receive
copies of the patent applications.
BILLING CODE 4140–01–P
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
Availability for licensing U.S.
Government owned intellectual
property for commercial development.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
patent applications listed below may be
obtained by emailing the indicated
licensing contact at the National Heart,
Lung, and Blood, Office of Technology
Transfer and Development Office of
Technology Transfer, 31 Center Drive
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:43 Sep 01, 2017
Jkt 241001
The
inventions listed below are owned by an
agency of the U.S. Government and are
available for licensing in the U.S. in
accordance with 35 U.S.C. 209 and 37
CFR part 404 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing. Technology description
follows.
Hybrid Computed Tomography
Scanning System
Description of Technology: The
invention relates to a combination
hybrid computed tomography (CT)
system that is particularly suited for
elucidating stages in pulmonary
diseases, notably cystic fibrosis and
lung cancer. Improved visualization of
lung parenchyma and the margins of
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
lung cysts and lung nodules (noninvasive ‘‘virtual biopsy’’) may provide
sufficient detail to distinguish the types
of cystic lesions and lung nodules such
that the typical lung tissue pathologic
biopsy would not be needed to make a
diagnosis. The system includes placing
one or more x-ray detector panels near
the patient’s body initially outside the
view of a CT scanner and then moved
into place for a secondary scan. An
initial low dose scan, CT scan or X-ray,
can be performed and if a highresolution CT scan is then necessary a
flat panel detector is positioned near the
area of interest. It is preferable that the
flat panel detector be transparent to
high-energy x-ray photons. The plurality
of acquired images are then
reconstructed into a low and highresolution image.
Potential Commercial Applications:
• Non-invasive lung biopsies
Development Stage:
• Early stage, no prototype.
Inventors: Han Wen (NHLBI)
Intellectual Property: HHS Reference
No. E–175–2017/0–US–01
• U.S. Provisional Patent Application
62/546,639 filed August 17, 2017.
E:\FR\FM\05SEN1.SGM
05SEN1
Federal Register / Vol. 82, No. 170 / Tuesday, September 5, 2017 / Notices
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@nih.gov.
Collaborative Research Opportunity:
The National Heart, Lung, and Blood
Institute seeks statements of capability
or interest from parties interested in
collaborative research to further develop
and evaluate, please contact Cecilia
Pazman, Ph.D., Technology
Development Specialist, Office of
Technology Transfer, National Heart,
Lung, and Blood Institute, Phone: (301)
594–4273; pazmance@nhlbi.nih.gov.
Dated: August 21, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2017–18670 Filed 9–1–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
mstockstill on DSK30JT082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Hearing
and Balance Clinical Trial Review.
Date: September 27, 2017.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, 301–496–8683, yangshi@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
VerDate Sep<11>2014
17:43 Sep 01, 2017
Jkt 241001
Disorders Special Emphasis Panel; U01
Review.
Date: September 29, 2017.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Kausik Ray, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health,
Rockville, MD 20850, 301–402–3587, rayk@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; VSL
Clinical Trial Review.
Date: October 5, 2017.
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, 301–496–8683, yangshi@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Institutional Research Training Grant
Review.
Date: October 10, 2017.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351, Bethesda, MD
20892, 301–496–8683, katherine.shim@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: August 29, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18672 Filed 9–1–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
41973
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2017–0019; OMB No.
1660–0061]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; Federal
Assistance to Individuals and
Households Program, (IHP)
Federal Emergency
Management Agency, DHS.
ACTION: Notice and request for
comments.
AGENCY:
The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on a reinstatement, without
change, of a previously approved
information collection for which
approval has expired. In accordance
with the Paperwork Reduction Act of
1995, this notice seeks comments
concerning the need to continue
collecting information from individuals
and States in order to provide and/or
administer disaster assistance through
the Federal Assistance to Individuals
and Households Programs.
DATES: Comments must be submitted on
or before October 5, 2017.
ADDRESSES: Submit written comments
on the proposed information collection
to the Office of Information and
Regulatory Affairs, Office of
Management and Budget. Comments
should be addressed to the Desk Officer
for the Department of Homeland
Security, Federal Emergency
Management Agency, and sent via
electronic mail to dhsdeskofficer@
omb.eop.gov.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
should be made to Director, Records
Management Division, 500 C Street SW.,
Washington, DC 20472, email address
FEMA-Information-CollectionsManagement@fema.dhs.gov or Elizabeth
McDowell, Program Specialist, 540–
686–3630.
SUPPLEMENTARY INFORMATION: The
Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C.
5121–5207 (the Act) is the legal basis for
FEMA to provide disaster related
assistance and services to individuals
who apply for disaster assistance
benefits in the event of a federally
E:\FR\FM\05SEN1.SGM
05SEN1
Agencies
[Federal Register Volume 82, Number 170 (Tuesday, September 5, 2017)]
[Notices]
[Pages 41972-41973]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18670]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions; Availability for Licensing
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Availability for licensing U.S. Government owned intellectual
property for commercial development.
FOR FURTHER INFORMATION CONTACT: Licensing information and copies of
the patent applications listed below may be obtained by emailing the
indicated licensing contact at the National Heart, Lung, and Blood,
Office of Technology Transfer and Development Office of Technology
Transfer, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892-2479;
telephone: 301-402-5579. A signed Confidential Disclosure Agreement may
be required to receive copies of the patent applications.
SUPPLEMENTARY INFORMATION: The inventions listed below are owned by an
agency of the U.S. Government and are available for licensing in the
U.S. in accordance with 35 U.S.C. 209 and 37 CFR part 404 to achieve
expeditious commercialization of results of federally-funded research
and development. Foreign patent applications are filed on selected
inventions to extend market coverage for companies and may also be
available for licensing. Technology description follows.
Hybrid Computed Tomography Scanning System
Description of Technology: The invention relates to a combination
hybrid computed tomography (CT) system that is particularly suited for
elucidating stages in pulmonary diseases, notably cystic fibrosis and
lung cancer. Improved visualization of lung parenchyma and the margins
of lung cysts and lung nodules (non-invasive ``virtual biopsy'') may
provide sufficient detail to distinguish the types of cystic lesions
and lung nodules such that the typical lung tissue pathologic biopsy
would not be needed to make a diagnosis. The system includes placing
one or more x-ray detector panels near the patient's body initially
outside the view of a CT scanner and then moved into place for a
secondary scan. An initial low dose scan, CT scan or X-ray, can be
performed and if a high-resolution CT scan is then necessary a flat
panel detector is positioned near the area of interest. It is
preferable that the flat panel detector be transparent to high-energy
x-ray photons. The plurality of acquired images are then reconstructed
into a low and high-resolution image.
Potential Commercial Applications:
Non-invasive lung biopsies
Development Stage:
Early stage, no prototype.
Inventors: Han Wen (NHLBI)
Intellectual Property: HHS Reference No. E-175-2017/0-US-01
U.S. Provisional Patent Application 62/546,639 filed
August 17, 2017.
[[Page 41973]]
Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019;
shmilovm@nih.gov.
Collaborative Research Opportunity: The National Heart, Lung, and
Blood Institute seeks statements of capability or interest from parties
interested in collaborative research to further develop and evaluate,
please contact Cecilia Pazman, Ph.D., Technology Development
Specialist, Office of Technology Transfer, National Heart, Lung, and
Blood Institute, Phone: (301) 594-4273; pazmance@nhlbi.nih.gov.
Dated: August 21, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood
Institute, Office of Technology Transfer and Development.
[FR Doc. 2017-18670 Filed 9-1-17; 8:45 am]
BILLING CODE 4140-01-P